{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:24:11Z","timestamp":1794306251171,"version":"4.9.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-64069-6","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T07:56:21Z","timestamp":1765698981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycopolymer binds pathogenic IgM autoantibodies and pulls them into the mononuclear phagocyte system for degradation"],"prefix":"10.1038","volume":"15","author":[{"given":"Butrint","family":"Aliu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Demeestere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf","family":"Heusermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Herrendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"H\u00e4nggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"64069_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/jnc.15021","volume":"154","author":"B Aliu","year":"2020","unstructured":"Aliu, B. et al. Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer. J. Neurochem. 154, 486 (2020).","journal-title":"J. Neurochem."},{"issue":"5","key":"64069_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/01.wco.0000245368.36576.0d","volume":"19","author":"AJ Steck","year":"2006","unstructured":"Steck, A. J., Stalder, A. K. & Renaud, S. Anti-myelin-associated glycoprotein neuropathy. Curr. Opin. Neurol. 19(5), 458\u2013463 (2006).","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"64069_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11940-010-0065-x","volume":"12","author":"MC Dalakas","year":"2010","unstructured":"Dalakas, M. C. Pathogenesis and treatment of Anti-MAG neuropathy. Curr. Treat. Options Neurol. 12(2), 71\u201383 (2010).","journal-title":"Curr. Treat. Options Neurol."},{"key":"64069_CR4","first-page":"CD002827","volume":"10","author":"MP Lunn","year":"2016","unstructured":"Lunn, M. P. & Nobile-Orazio, E. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst. Rev. 10, CD002827 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"64069_CR5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s00415-017-8502-3","volume":"264","author":"M Baron","year":"2017","unstructured":"Baron, M. et al. Plasma exchanges for severe acute neurological deterioration in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) neuropathy. J. Neurol. 264(6), 1132\u20131135 (2017).","journal-title":"J. Neurol."},{"issue":"2","key":"64069_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1529-8027.2007.00129.x","volume":"12","author":"L Benedetti","year":"2007","unstructured":"Benedetti, L. et al. Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. J. Peripher. Nerv. Syst. 12(2), 102\u2013107 (2007).","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"5","key":"64069_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1212\/01.wnl.0000201193.00382.b3","volume":"66","author":"S Renaud","year":"2006","unstructured":"Renaud, S. et al. High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology 66(5), 742\u2013744 (2006).","journal-title":"Neurology"},{"issue":"1","key":"64069_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ana.410240118","volume":"24","author":"E Nobile-Orazio","year":"1988","unstructured":"Nobile-Orazio, E. et al. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann. Neurol. 24(1), 93\u201397 (1988).","journal-title":"Ann. Neurol."},{"issue":"5","key":"64069_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s004010050835","volume":"95","author":"JM Gabriel","year":"1998","unstructured":"Gabriel, J. M. et al. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol. 95(5), 540\u2013546 (1998).","journal-title":"Acta Neuropathol."},{"issue":"4","key":"64069_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/jnnp.74.4.485","volume":"74","author":"A Pestronk","year":"2003","unstructured":"Pestronk, A. et al. Treatment of IgM antibody associated polyneuropathies using rituximab. J. Neurol. Neurosurg. Psychiatry 74(4), 485\u2013489 (2003).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"18","key":"64069_CR11","doi-asserted-by":"publisher","first-page":"E3689","DOI":"10.1073\/pnas.1619386114","volume":"114","author":"R Herrendorff","year":"2017","unstructured":"Herrendorff, R. et al. Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy. Proc. Natl. Acad. Sci. U. S. A. 114(18), E3689\u2013E3698 (2017).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"64069_CR12","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1021\/bi9002919","volume":"48","author":"TK Dam","year":"2009","unstructured":"Dam, T. K., Gerken, T. A. & Brewer, C. F. Thermodynamics of multivalent carbohydrate-lectin cross-linking interactions: Importance of entropy in the bind and jump mechanism. Biochemistry 48(18), 3822\u20133827 (2009).","journal-title":"Biochemistry"},{"issue":"6","key":"64069_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1367-5931(00)00153-8","volume":"4","author":"LL Kiessling","year":"2000","unstructured":"Kiessling, L. L., Gestwicki, J. E. & Strong, L. E. Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr. Opin. Chem. Biol. 4(6), 696\u2013703 (2000).","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"4","key":"64069_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1021\/acs.chemrev.5b00247","volume":"116","author":"Y Miura","year":"2016","unstructured":"Miura, Y., Hoshino, Y. & Seto, H. Glycopolymer Nanobiotechnology. Chem. Rev. 116(4), 1673\u20131692 (2016).","journal-title":"Chem. Rev."},{"issue":"2","key":"64069_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/bm050672n","volume":"7","author":"BD Polizzotti","year":"2006","unstructured":"Polizzotti, B. D. & Kiick, K. L. Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers. Biomacromolecules 7(2), 483\u2013490 (2006).","journal-title":"Biomacromolecules"},{"issue":"2","key":"64069_CR16","doi-asserted-by":"publisher","first-page":"e0006266","DOI":"10.1371\/journal.pntd.0006266","volume":"12","author":"S Das","year":"2018","unstructured":"Das, S. et al. Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera. PLoS Negl. Trop. Dis. 12(2), e0006266 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"31","key":"64069_CR17","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1002\/anie.201202945","volume":"51","author":"SJ Richards","year":"2012","unstructured":"Richards, S. J., Jones, M. W., Hunaban, M., Haddleton, D. M. & Gibson, M. I. Probing bacterial-toxin inhibition with synthetic glycopolymers prepared by tandem post-polymerization modification: Role of linker length and carbohydrate density. Angew. Chem. Int. Ed. Engl. 51(31), 7812\u20137816 (2012).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"64069_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1021\/acs.bioconjchem.8b00902","volume":"30","author":"D Haksar","year":"2019","unstructured":"Haksar, D. et al. Strong inhibition of cholera toxin B subunit by affordable, polymer-based multivalent inhibitors. Bioconjug. Chem. 30(3), 785\u2013792 (2019).","journal-title":"Bioconjug. Chem."},{"issue":"3","key":"64069_CR19","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1128\/IAI.74.3.1984-1988.2006","volume":"74","author":"M Watanabe","year":"2006","unstructured":"Watanabe, M. et al. Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues. Infect. Immun. 74(3), 1984\u20131988 (2006).","journal-title":"Infect. Immun."},{"issue":"2","key":"64069_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1021\/am201493q","volume":"4","author":"T Nagatsuka","year":"2012","unstructured":"Nagatsuka, T. et al. Glycotechnology for decontamination of biological agents: A model study using ricin and biotin-tagged synthetic glycopolymers. ACS Appl. Mater. Interfaces 4(2), 832\u2013837 (2012).","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"64069_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1172\/JCI16526","volume":"110","author":"AG Katopodis","year":"2002","unstructured":"Katopodis, A. G. et al. Removal of anti-Galalpha 1,3Gal xenoantibodies with an injectable polymer. J. Clin. Invest. 110(12), 1869\u20131877 (2002).","journal-title":"J. Clin. Invest."},{"key":"64069_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jconrel.2015.09.043","volume":"219","author":"J Li","year":"2015","unstructured":"Li, J., Yu, F., Chen, Y. & Oupick\u00fd, D. Polymeric drugs: Advances in the development of pharmacologically active polymers. J. Control Release 219, 369\u2013382 (2015).","journal-title":"J. Control Release"},{"issue":"4","key":"64069_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"I Ekladious","year":"2019","unstructured":"Ekladious, I., Colson, Y. L. & Grinstaff, M. W. Polymer-drug conjugate therapeutics: Advances, insights and prospects. Nat. Rev. Drug Discov. 18(4), 273\u2013294 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"64069_CR24","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.1021\/acsnano.7b04630","volume":"11","author":"M Bartneck","year":"2017","unstructured":"Bartneck, M. et al. Immunomodulatory therapy of inflammatory liver disease using selectin-binding glycopolymers. ACS Nano 11(10), 9689\u20139700 (2017).","journal-title":"ACS Nano"},{"issue":"21\u201322","key":"64069_CR25","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.drudis.2013.06.014","volume":"18","author":"A Aied","year":"2013","unstructured":"Aied, A., Greiser, U., Pandit, A. & Wang, W. Polymer gene delivery: Overcoming the obstacles. Drug Discov. Today 18(21\u201322), 1090\u20131098 (2013).","journal-title":"Drug Discov. Today"},{"issue":"10","key":"64069_CR26","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","volume":"30","author":"SA Kulkarni","year":"2013","unstructured":"Kulkarni, S. A. & Feng, S. S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm. Res. 30(10), 2512\u20132522 (2013).","journal-title":"Pharm. Res."},{"issue":"13","key":"64069_CR27","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","volume":"31","author":"C He","year":"2010","unstructured":"He, C., Hu, Y., Yin, L., Tang, C. & Yin, C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13), 3657\u20133666 (2010).","journal-title":"Biomaterials"},{"issue":"4","key":"64069_CR28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijbiomac.2012.02.021","volume":"50","author":"D Zhou","year":"2012","unstructured":"Zhou, D. et al. Glycopolymer modification on physicochemical and biological properties of poly(L-lysine) for gene delivery. Int. J. Biol. Macromol. 50(4), 965\u2013973 (2012).","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"64069_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0192623314526475","volume":"42","author":"JL Rojko","year":"2014","unstructured":"Rojko, J. L. et al. Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: Review and case studies. Toxicol. Pathol. 42(4), 725\u2013764 (2014).","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"64069_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s11671-018-2457-x","volume":"13","author":"A Sukhanova","year":"2018","unstructured":"Sukhanova, A. et al. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res. Lett. 13(1), 44 (2018).","journal-title":"Nanoscale Res. Lett."},{"issue":"4","key":"64069_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5(4), 505\u2013515 (2008).","journal-title":"Mol. Pharm."},{"issue":"4","key":"64069_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s12272-001-1191-8","volume":"31","author":"M Liu","year":"2008","unstructured":"Liu, M., Li, H., Luo, G., Liu, Q. & Wang, Y. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch. Pharm. Res. 31(4), 547\u2013554 (2008).","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"64069_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"DE Owens","year":"2006","unstructured":"Owens, D. E. & Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1), 93\u2013102 (2006).","journal-title":"Int. J. Pharm."},{"issue":"6","key":"64069_CR34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/cmi.12403","volume":"17","author":"L Stevenson","year":"2015","unstructured":"Stevenson, L. et al. Investigating the function of Fc-specific binding of IgM to Plasmodium falciparum erythrocyte membrane protein 1 mediating erythrocyte rosetting. Cell Microbiol. 17(6), 819\u2013831 (2015).","journal-title":"Cell Microbiol."},{"issue":"3","key":"64069_CR35","doi-asserted-by":"publisher","first-page":"e0120820","DOI":"10.1371\/journal.pone.0120820","volume":"10","author":"K Schilling","year":"2015","unstructured":"Schilling, K. & Krause, F. Analysis of antibody aggregate content at extremely high concentrations using sedimentation velocity with a novel interference optics. PLoS One 10(3), e0120820 (2015).","journal-title":"PLoS One"},{"issue":"1","key":"64069_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0168-3659(00)00293-5","volume":"69","author":"H Ishiwata","year":"2000","unstructured":"Ishiwata, H., Suzuki, N., Ando, S., Kikuchi, H. & Kitagawa, T. Characteristics and biodistribution of cationic liposomes and their DNA complexes. J. Control Release 69(1), 139\u2013148 (2000).","journal-title":"J. Control Release"},{"issue":"1","key":"64069_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbamem.2004.10.013","volume":"1668","author":"C Rothkopf","year":"2005","unstructured":"Rothkopf, C., Fahr, A., Fricker, G., Scherphof, G. L. & Kamps, J. A. Uptake of phosphatidylserine-containing liposomes by liver sinusoidal endothelial cells in the serum-free perfused rat liver. Biochim. Biophys. Acta 1668(1), 10\u201316 (2005).","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"64069_CR38","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1021\/bm101482r","volume":"12","author":"ZG Yue","year":"2011","unstructured":"Yue, Z. G. et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 12(7), 2440\u20132446 (2011).","journal-title":"Biomacromolecules"},{"key":"64069_CR39","doi-asserted-by":"publisher","first-page":"30433","DOI":"10.1038\/srep30433","volume":"6","author":"R Rasmussen","year":"2016","unstructured":"Rasmussen, R., Nedergaard, M. & Petersen, N. C. Sulforhodamine 101, a widely used astrocyte marker, can induce cortical seizure-like activity at concentrations commonly used. Sci. Rep. 6, 30433 (2016).","journal-title":"Sci. Rep."},{"issue":"8","key":"64069_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 5(8), 606\u2013616 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"64069_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms18061249","volume":"18","author":"M Cataldi","year":"2017","unstructured":"Cataldi, M., Vigliotti, C., Mosca, T., Cammarota, M. & Capone, D. Emerging role of the spleen in the pharmacokinetics of monoclonal antibodies, nanoparticles and exosomes. Int. J. Mol. Sci. 18, 6 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"64069_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/eji.1830111013","volume":"11","author":"JM Austyn","year":"1981","unstructured":"Austyn, J. M. & Gordon, S. F4\/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11(10), 805\u2013815 (1981).","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"64069_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00418-009-0577-1","volume":"131","author":"JL Baratta","year":"2009","unstructured":"Baratta, J. L. et al. Cellular organization of normal mouse liver: A histological, quantitative immunocytochemical, and fine structural analysis. Histochem. Cell Biol. 131(6), 713\u2013726 (2009).","journal-title":"Histochem. Cell Biol."},{"issue":"3","key":"64069_CR44","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1021\/acsnano.7b06995","volume":"12","author":"F Campbell","year":"2018","unstructured":"Campbell, F. et al. Directing nanoparticle biodistribution through evasion and exploitation of Stab2-dependent nanoparticle uptake. ACS Nano 12(3), 2138\u20132150 (2018).","journal-title":"ACS Nano"},{"issue":"1","key":"64069_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tiv.2015.09.030","volume":"30","author":"H Kettiger","year":"2015","unstructured":"Kettiger, H., Sen-Karaman, D., Schiesser, L., Rosenholm, J. M. & Huwyler, J. Comparative safety evaluation of silica-based particles. Toxicol. In Vitro 30(1), 355\u2013363 (2015).","journal-title":"Toxicol. In Vitro"},{"issue":"11","key":"64069_CR46","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1128\/IAI.67.11.5573-5578.1999","volume":"67","author":"S Takashiba","year":"1999","unstructured":"Takashiba, S. et al. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect. Immun. 67(11), 5573\u20135578 (1999).","journal-title":"Infect. Immun."},{"key":"64069_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jim.2016.02.001","volume":"431","author":"N Nath","year":"2016","unstructured":"Nath, N. et al. Homogeneous plate based antibody internalization assay using pH sensor fluorescent dye. J. Immunol. Methods 431, 11\u201321 (2016).","journal-title":"J. Immunol. Methods"},{"key":"64069_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev-pathol-011811-132445","volume":"7","author":"RS Flannagan","year":"2012","unstructured":"Flannagan, R. S., Jaumouill\u00e9, V. & Grinstein, S. The cell biology of phagocytosis. Annu. Rev. Pathol. 7, 61\u201398 (2012).","journal-title":"Annu. Rev. Pathol."},{"issue":"9","key":"64069_CR49","doi-asserted-by":"publisher","first-page":"e24438","DOI":"10.1371\/journal.pone.0024438","volume":"6","author":"T dos Santos","year":"2011","unstructured":"dos Santos, T., Varela, J., Lynch, I., Salvati, A. & Dawson, K. A. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 6(9), e24438 (2011).","journal-title":"PLoS One"},{"issue":"7","key":"64069_CR50","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.4049\/jimmunol.1000989","volume":"185","author":"T Thelen","year":"2010","unstructured":"Thelen, T. et al. The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J. Immunol. 185(7), 4328\u20134335 (2010).","journal-title":"J. Immunol."},{"issue":"8","key":"64069_CR51","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/glycob\/cwn045","volume":"18","author":"EN Harris","year":"2008","unstructured":"Harris, E. N. & Weigel, P. H. The ligand-binding profile of HARE: Hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E. Glycobiology 18(8), 638\u2013648 (2008).","journal-title":"Glycobiology"},{"issue":"48","key":"64069_CR52","doi-asserted-by":"publisher","first-page":"47562","DOI":"10.1074\/jbc.M308428200","volume":"278","author":"G Marsche","year":"2003","unstructured":"Marsche, G. et al. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J. Biol. Chem. 278(48), 47562\u201347570 (2003).","journal-title":"J. Biol. Chem."},{"issue":"Pt 14","key":"64069_CR53","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1242\/jcs.114.14.2673","volume":"114","author":"DJ Seastone","year":"2001","unstructured":"Seastone, D. J. et al. The WASp-like protein scar regulates macropinocytosis, phagocytosis and endosomal membrane flow in Dictyostelium. J. Cell Sci. 114(Pt 14), 2673\u20132683 (2001).","journal-title":"J. Cell Sci."},{"issue":"10","key":"64069_CR54","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.4049\/jimmunol.1700373","volume":"198","author":"MR PrabhuDas","year":"2017","unstructured":"PrabhuDas, M. R. et al. A consensus definitive classification of scavenger receptors and their roles in health and disease. J. Immunol. 198(10), 3775\u20133789 (2017).","journal-title":"J. Immunol."},{"issue":"3","key":"64069_CR55","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1046\/j.1432-1327.2000.01077.x","volume":"267","author":"NA Elshourbagy","year":"2000","unstructured":"Elshourbagy, N. A. et al. Molecular characterization of a human scavenger receptor, human MARCO. Eur. J. Biochem. 267(3), 919\u2013926 (2000).","journal-title":"Eur. J. Biochem."},{"issue":"2","key":"64069_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000155227","volume":"1","author":"A Pl\u00fcddemann","year":"2009","unstructured":"Pl\u00fcddemann, A. et al. SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: An example of fine specificity in microbial ligand recognition by innate immune receptors. J. Innate Immun. 1(2), 153\u2013163 (2009).","journal-title":"J. Innate Immun."},{"issue":"8","key":"64069_CR57","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","volume":"87","author":"P Godoy","year":"2013","unstructured":"Godoy, P. et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch. Toxicol. 87(8), 1315\u20131530 (2013).","journal-title":"Arch. Toxicol."},{"key":"64069_CR58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-3-030-29168-6_10","volume-title":"Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis","author":"AS Lokhande","year":"2019","unstructured":"Lokhande, A. S., Jahagirdar, P., Dandekar, P. & Devarajan, P. V. Scavenger receptor and targeting strategies. In Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis (eds Devarajan, P. V. et al.) 297\u2013321 (Springer International Publishing, 2019)."},{"key":"64069_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-60327-198-1_6","volume":"697","author":"JD Clogston","year":"2011","unstructured":"Clogston, J. D. & Patri, A. K. Zeta potential measurement. Methods Mol. Biol. 697, 63\u201370 (2011).","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"64069_CR60","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","volume":"78","author":"P Schuck","year":"2000","unstructured":"Schuck, P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78(3), 1606\u20131619 (2000).","journal-title":"Biophys. J."},{"key":"64069_CR61","unstructured":"First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy. ClinicalTrials.gov identifier: NCT04568174 (2021, accessed 15 Jul 2022). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT0456817."},{"key":"64069_CR62","unstructured":"Steck, A. J. An antigen-specific treatment option for anti-MAG neuropathy. In 8th Translational Research Meeting on Peripheral Neuropathies. Piti\u00e9-Salpetri\u00e8re, Paris, France (2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64069-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:05:00Z","timestamp":1766066700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64069-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64069"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-64069-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"19 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.H., P.H., and B.E. are co-founders of the University of Basel spin-off, Polyneuron Pharmaceuticals AG, whose activity is related to the subject matter of this article. R.H. and B.E. are named as co-inventors on relevant patent applications. Other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43852"}}